Jason S. Knight, Ph.D. - Publications

Affiliations: 
2005 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Microbiology Biology, Virology Biology

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Grenn RC, Yalavarthi S, Gandhi AA, Kazzaz NM, Núñez-Álvarez C, Hernández-Ramírez D, Cabral AR, McCune WJ, Bockenstedt PL, Knight JS. Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome. Annals of the Rheumatic Diseases. PMID 27432357 DOI: 10.1136/annrheumdis-2016-209442  0.96
2016 Wang H, Knight JS, Hodgin JB, Wang J, Guo C, Kleiman K, Eitzman DT. Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus. Scientific Reports. 6: 28997. PMID 27357136 DOI: 10.1038/srep28997  0.96
2016 Kazzaz NM, McCune WJ, Knight JS. Treatment of catastrophic antiphospholipid syndrome. Current Opinion in Rheumatology. 28: 218-27. PMID 26927441 DOI: 10.1097/BOR.0000000000000269  0.96
2016 Yalavarthi S, Knight JS. Low-density granulocytes as a potential source of neutrophil extracellular traps in antiphospholipid syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26748667 DOI: 10.1002/art.39579  0.96
2015 Kazzaz NM, Coit P, Lewis EE, McCune WJ, Sawalha AH, Knight JS. Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival. Lupus Science & Medicine. 2: e000117. PMID 26430514 DOI: 10.1136/lupus-2015-000117  0.96
2015 Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C, Hernández-Ramírez D, Bockenstedt PL, Liaw PC, Cabral AR, Knight JS. Antiphospholipid antibodies promote the release of neutrophil extracellular traps: A new mechanism of thrombosis in the antiphospholipid syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26097119 DOI: 10.1002/art.39247  0.96
2015 Subramanian V, Knight JS, Parelkar S, Anguish L, Coonrod SA, Kaplan MJ, Thompson PR. Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors. Journal of Medicinal Chemistry. 58: 1337-44. PMID 25559347 DOI: 10.1021/jm501636x  0.96
2014 Knight JS, Blayney DW, Somers EC. Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy. Lupus Science & Medicine. 1: e000051. PMID 25452880 DOI: 10.1136/lupus-2014-000051  0.96
2014 Knight JS, Subramanian V, O'Dell AA, Yalavarthi S, Zhao W, Smith CK, Hodgin JB, Thompson PR, Kaplan MJ. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Annals of the Rheumatic Diseases. PMID 25104775 DOI: 10.1136/annrheumdis-2014-205365  0.96
2014 Smith CK, Vivekanandan-Giri A, Tang C, Knight JS, Mathew A, Padilla RL, Gillespie BW, Carmona-Rivera C, Liu X, Subramanian V, Hasni S, Thompson PR, Heinecke JW, Saran R, Pennathur S, et al. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). 66: 2532-44. PMID 24838349 DOI: 10.1002/art.38703  0.96
2014 Knight JS, Luo W, O'Dell AA, Yalavarthi S, Zhao W, Subramanian V, Guo C, Grenn RC, Thompson PR, Eitzman DT, Kaplan MJ. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circulation Research. 114: 947-56. PMID 24425713 DOI: 10.1161/CIRCRESAHA.114.303312  0.96
2014 Palanichamy A, Bauer JW, Yalavarthi S, Meednu N, Barnard J, Owen T, Cistrone C, Bird A, Rabinovich A, Nevarez S, Knight JS, Dedrick R, Rosenberg A, Wei C, Rangel-Moreno J, et al. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. Journal of Immunology (Baltimore, Md. : 1950). 192: 906-18. PMID 24379124 DOI: 10.4049/jimmunol.1302112  0.96
2013 Knight JS, Kaplan MJ. Cardiovascular disease in lupus: insights and updates. Current Opinion in Rheumatology. 25: 597-605. PMID 23846339 DOI: 10.1097/BOR.0b013e328363eba3  0.96
2013 Knight JS, Zhao W, Luo W, Subramanian V, O'Dell AA, Yalavarthi S, Hodgin JB, Eitzman DT, Thompson PR, Kaplan MJ. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. The Journal of Clinical Investigation. 123: 2981-93. PMID 23722903 DOI: 10.1172/JCI67390  0.96
2013 Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V, Thompson P, Chen P, Fox DA, Pennathur S, Kaplan MJ. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Science Translational Medicine. 5: 178ra40. PMID 23536012 DOI: 10.1126/scitranslmed.3005580  0.96
2012 Knight JS, Carmona-Rivera C, Kaplan MJ. Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases. Frontiers in Immunology. 3: 380. PMID 23248629 DOI: 10.3389/fimmu.2012.00380  0.96
2012 Knight JS, Kaplan MJ. Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis. Current Opinion in Rheumatology. 24: 441-50. PMID 22617827 DOI: 10.1097/BOR.0b013e3283546703  0.96
2009 Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3354-62. PMID 19451438 DOI: 10.1200/JCO.2008.20.0857  0.96
2009 Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology. 388: 236-47. PMID 19394062 DOI: 10.1016/j.virol.2009.03.027  0.96
2008 Murakami M, Meneses PI, Knight JS, Lan K, Kaul R, Verma SC, Robertson ES. Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1. International Journal of Cancer. Journal International Du Cancer. 123: 500-10. PMID 18470881 DOI: 10.1002/ijc.23568  0.96
2006 Cai QL, Knight JS, Verma SC, Zald P, Robertson ES. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. Plos Pathogens. 2: e116. PMID 17069461 DOI: 10.1371/journal.ppat.0020116  0.96
2006 Knight JS, Lan K, Bajaj B, Sharma N, Tsai DE, Robertson ES. A peptide-based inhibitor for prevention of B cell hyperproliferation induced by Epstein-Barr virus. Virology. 354: 207-14. PMID 16876848 DOI: 10.1016/j.virol.2006.06.034  0.96
2006 Sharma N, Knight JS, Robertson ES. Conserved cell cycle regulatory properties within the amino terminal domain of the Epstein-Barr virus nuclear antigen 3C. Virology. 346: 379-84. PMID 16364389 DOI: 10.1016/j.virol.2005.11.023  0.96
2005 Knight JS, Sharma N, Robertson ES. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proceedings of the National Academy of Sciences of the United States of America. 102: 18562-6. PMID 16352731 DOI: 10.1073/pnas.0503886102  0.96
2005 Kuppers DA, Lan K, Knight JS, Robertson ES. Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1. Journal of Virology. 79: 9714-24. PMID 16014933 DOI: 10.1128/JVI.79.15.9714-9724.2005  0.96
2005 Knight JS, Sharma N, Robertson ES. SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Molecular and Cellular Biology. 25: 1749-63. PMID 15713632 DOI: 10.1128/MCB.25.5.1749-1763.2005  0.96
2005 Knight JS, Verma SC, Lan K, Robertson ES. Molecular genetics of herpesviruses: a recombinant technology approach. Methods in Molecular Biology (Clifton, N.J.). 292: 333-52. PMID 15507719  0.96
2004 Knight JS, Sharma N, Kalman DE, Robertson ES. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells. Journal of Virology. 78: 12857-67. PMID 15542638 DOI: 10.1128/JVI.78.23.12857-12867.2004  0.96
2004 Knight JS, Robertson ES. Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity. Journal of Virology. 78: 1981-91. PMID 14747563 DOI: 10.1128/JVI.78.4.1981-1991.2004  0.96
2003 Knight JS, Lan K, Subramanian C, Robertson ES. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. Journal of Virology. 77: 4261-72. PMID 12634383 DOI: 10.1128/JVI.77.7.4261-4272.2003  0.96
2002 Subramanian C, Knight JS, Robertson ES. The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration. Frontiers in Bioscience : a Journal and Virtual Library. 7: d704-16. PMID 11861219  0.96
2001 Knight JS, Cotter MA, Robertson ES. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter. The Journal of Biological Chemistry. 276: 22971-8. PMID 11313352 DOI: 10.1074/jbc.M101890200  0.96
Show low-probability matches.